CARDIOVASCULAR TOXICITY IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS TREATED WITH COMBINATIONS OF PARP-INHIBITOR AND ABIRATERONE: A META-ANALYSIS

ANTICANCER RESEARCH(2022)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要